Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $23 | $0 | $0 |
| Short-Term Investments | $23 | $23 | $24 | $23 |
| Receivables | $30 | $29 | $23 | $23 |
| Inventory | $25 | $26 | $23 | $19 |
| Other Curr. Assets | $4 | $4 | $5 | $4 |
| Total Curr. Assets | $107 | $105 | $101 | $99 |
| Property Plant & Equip (Net) | $27 | $25 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $2 | $2 |
| Long-Term Investments | $108 | $129 | $1 | $1 |
| Tax Assets | $1 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | -$1 | -$1 |
| Total NC Assets | $137 | $156 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $244 | $261 | $2 | $2 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $2 |
| Tax Payable | $1 | $2 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $9 | $9 | $13 |
| Total Curr. Liab. | $17 | $18 | $15 | $19 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $16 | $21 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $0 | $0 |
| Total NC Liab. | $17 | $22 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $34 | $40 | $0 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $24 | $24 | $24 | $24 |
| Retained Earnings | $131 | $127 | $126 | $118 |
| AOCI | $0 | $0 | $33 | $48 |
| Other Equity | $53 | $68 | $11 | $11 |
| Total Equity | $209 | $220 | $194 | $201 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1 | $1 | $0 | $0 |
| Total Liab. & Tot. Equity | $244 | $261 | $2 | $2 |
| Net Debt | -$24 | -$22 | $1 | $1 |